Oramed Pharmaceuticals Inc. (ORMP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oramed Pharmaceuticals In...

    NASDAQ: ORMP · Real-Time Price · USD
    2.44
    -0.07 (-2.93%)
    At close: Oct 03, 2025, 3:59 PM
    2.48
    1.64%
    After-hours: Oct 03, 2025, 07:11 PM EDT

    Oramed Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
    PE Ratio
    		 -5.17 16.86 -12.42 -25.19
    PEG Ratio
    		 0.01 -0.15 -0.51 -0.64
    PS Ratio
    		 n/a 69.50 173.56 207.28
    PB Ratio
    		 0.68 0.57 3.09 4.84
    P/FCF Ratio
    		 -11.72 -8.83 -16.51 -25.99
    P/OCF Ratio
    		 -11.75 -9.05 -16.8 -26.45
    OCF/S Ratio
    		 n/a -7.68 -10.33 -7.84
    Debt / Equity Ratio
    		 0.00 0.32 0.01 0.00
    Quick Ratio
    		 25.19 3.06 27.34 14.27
    Current Ratio
    		 25.19 3.06 27.34 14.27
    Asset Turnover
    		 n/a 0.01 0.02 0.02
    Interest Coverage
    		 -14.98 -4.4 n/a -4.04K
    Return on Equity
    		 -0.13 0.03 -0.25 -0.19
    Return on Assets
    		 -0.12 0.03 -0.23 -0.17
    Return on Invested Capital
    		 -0.1 -0.07 -0.26 -0.17
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a 1.00 1.00 1.00
    Net Profit Margin
    		 n/a 4.12 -13.97 -8.23
    Pretax Profit Margin
    		 n/a 3.80 -13.93 -8.5
    Operating Profit Margin
    		 n/a -11.77 -15.02 -8.96
    FCF Margin
    		 n/a -7.87 -10.51 -7.97
    EBITDA Margin
    		 n/a -11.62 -13.68 -9.26

    Add to Watchlist